White Matter Hyperintensity May Serve as Biomarker for SCD, Study Says
An analysis of white matter hyperintensity (WMH, a measure of the risk of stroke) may serve as a biomarker to track the progression of blood vessel anomalies associated with sickle cell disease (SCD) and to check whether treatments were effective, according to new research. The research study, “Enhanced Long-Term…